Insider Transactions in Q1 2021 at Cue Biopharma, Inc. (CUE)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 16
2021
|
Kenneth Pienta Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
439
-18.0%
|
$6,585
$15.09 P/Share
|
|
Mar 16
2021
|
Kenneth Pienta Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
439
+15.25%
|
$2,195
$5.0 P/Share
|
|
Mar 15
2021
|
Kenneth Pienta Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
13,000
-86.67%
|
$195,000
$15.1 P/Share
|
|
Mar 15
2021
|
Kenneth Pienta Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,000
+46.43%
|
$65,000
$5.0 P/Share
|
|
Feb 17
2021
|
Kenneth Pienta Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,274
-68.12%
|
$64,110
$15.05 P/Share
|
|
Feb 17
2021
|
Kenneth Pienta Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,274
+30.19%
|
$12,822
$3.93 P/Share
|
|
Feb 16
2021
|
Kenneth Pienta Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
16,000
-88.89%
|
$240,000
$15.15 P/Share
|
|
Feb 16
2021
|
Kenneth Pienta Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,000
+47.06%
|
$32,000
$2.86 P/Share
|
|
Jan 20
2021
|
Kenneth Pienta Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
2,720
+36.56%
|
$40,800
$15.07 P/Share
|